This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by HERINGTON, A. C. Articles by BURGER, H. G. Search for Related Content PubMed PubMed Citation Articles by HERINGTON, A. C. Articles by BURGER, H. G.

Studies on the Possible Mechanism for Deficiency of Nonsuppressible Insulin-Like Activity in Thalassemia Major^*

Medical Research Centre, Prince Henry's Hospital Melbourne, 3004, Australia

Address requests for reprints to: Dr. Adrian C. Herington, Prince Henry's Hospital, St. Kilda Road, Melbourne 3004, Australia.

Previous studies have shown that serum levels of the somatomedin, nonsuppressible insulin-like activity (NSILA-S), are extremely low in patients with thalassemia major. Since these patients are not GH deficient, several other possible mechanisms for the reduced levels of NSILA-S have been explored. No evidence for the presence of NSILA inhibitors was obtained either in mixing experiments of normal serum and thalassemic sera or after acid gel chromatography of thalassemic sera. The high iron and ferritin levels of thalassemia had no effects on the NSILA-S bioassay itself or on the binding of GH to its hepatic receptors. GH molecules secreted as a result of exercise-induced GH stimulation tests were shown to be both immunologically and biologically reactive. No circulating GH-binding proteins were present in thalassemic sera. Since the liver function in the group of patients included in this study was only slightly abnormal, it is considered unlikely that generalized hepatic damage due to the severe iron overload of thalassemia is a major cause. These results suggest that neither NSILA-S inhibitors, abnormal GH molecules, nor hepatic damage contribute to the failure of these patients to produce NSILA-S and that a specific defect may exist at the hepatic GH receptor or postreceptor level. (J Clin Endocrinol Metab52: 393, 1981)

^* This work was supported by the National Health and Medical Research Council of Australia.

Received August 4, 1980.